Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda RolloutMerck plans to launch a subcutaneous Keytruda for cancer treatment in the US, awaiting FDA approval by September 23.
Man Loses Most of His Penis After Filler Procedure—Doctor Blames the PatientIn a harrowing tale that has caught the attention of many, a man faced devastating consequences after undergoing a penile filler procedure.
Top 10 Essential Shots You Need Beyond COVID-19Don't forget non-COVID vaccines! Protect against diseases like Hepatitis B, Cervical Cancer, and Meningococcal Infection.
Must-Reads
1
Coupang discloses 33m-user data breach to US regulators
LATEST
2
N. Korea's Kim pays respects to late father at family mausoleum on death anniversary
LATEST
3
Ex-vice land minister arrested over favoritism allegations related to presidential residence relocation
LATEST
4
Seoul stocks open higher amid mixed US job data
LATEST
5
US job growth snaps back; shutdown distorts unemployment rate
Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout Merck plans to launch a subcutaneous Keytruda for cancer treatment in the US, awaiting FDA approval by September 23.
Man Loses Most of His Penis After Filler Procedure—Doctor Blames the Patient In a harrowing tale that has caught the attention of many, a man faced devastating consequences after undergoing a penile filler procedure.
Top 10 Essential Shots You Need Beyond COVID-19 Don't forget non-COVID vaccines! Protect against diseases like Hepatitis B, Cervical Cancer, and Meningococcal Infection.
Hot Topics